tiprankstipranks
Trending News
More News >
Armata Pharmaceuticals Inc (ARMP)
XASE:ARMP
US Market

Armata Pharmaceuticals (ARMP) Income Statement

Compare
297 Followers

Armata Pharmaceuticals Income Statement

Last quarter (Q3 2025), Armata Pharmaceuticals's total revenue was $1.16M, a decrease of -61.02% from the same quarter last year. In Q3, Armata Pharmaceuticals's net income was $-26.68M. See Armata Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 5.17M$ 4.53M$ 5.51M$ 4.47M$ 823.00K
Gross Profit
$ -29.25M$ 3.56M$ -29.51M$ -15.54M$ -13.62M
Operating Expenses
$ 13.18M$ 44.45M$ 7.44M$ 8.28M$ 7.97M
Depreciation and Amortization
$ 1.32M$ 972.00K$ 892.00K$ 1.17M$ 1.11M
EBITDA
$ -41.11M$ -65.45M$ -36.05M$ -21.92M$ -20.44M
Operating Income
$ -42.44M$ -40.89M$ -36.95M$ -23.82M$ -21.59M
Other Income/Expenses
$ 23.52M$ -28.16M$ 29.00K$ 667.00K$ -594.00K
Pretax Income
$ -18.92M$ -69.05M$ -36.92M$ -23.16M$ -22.18M
Net Income
$ -18.92M$ -69.05M$ -36.92M$ -23.16M$ -22.18M
Per Share Metrics
Basic EPS
$ -0.52$ -1.91$ -1.08$ -0.96$ -1.35
Diluted EPS
$ -0.52$ -1.91$ -1.08$ -0.96$ -1.35
Weighted Average Shares Outstanding
36.16M 36.08M 34.29M 24.10M 16.41M
Weighted Average Shares Outstanding (Diluted)
36.16M 36.08M 34.29M 24.10M 16.41M
Currency in USD

Armata Pharmaceuticals Earnings and Revenue History